Matthew Angel - 12 Jan 2023 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Role
President and CEO, Director
Signature
/s/ Matthew Angel
Issuer symbol
ERNA
Transactions as of
12 Jan 2023
Net transactions value
$0
Form type
4
Filing time
13 Jan 2023, 18:30:32 UTC
Previous filing
03 Aug 2022
Next filing
06 Feb 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Stock Option (right to buy) Award $0 +132,003 $0.000000 132,003 12 Jan 2023 Common Stock, par value $0.005 per share 132,003 $4.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vests and becomes exercisable over three years (subject to continued service), with 110,043 of the shares vesting on the grant date, and the remaining shares vesting in 36 substantially equal monthly tranches on the first day of each month thereafter.